Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF-mutated melanoma and other advanced malignancies.

Name: Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF-mutated melanoma and other advanced malignancies.
Author: Bhatty, Minny

Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF-mutated melanoma and other advanced malignancies. — المؤلف: Bhatty, Minny — Cancer 20191126

المؤلف: Bhatty, Minny
النشر: Cancer 20191126
الوصف: 463-472 p.
الموضوعات: Adult؛ Aged؛ Antineoplastic Combined Chemotherapy Protocols؛ Carboplatin؛ Disease Progression؛ Female؛ Humans؛ Male